Whalesbook
📉 The Financial Deep Dive
The Numbers:
Sagility Limited reported an exceptional Q3 FY2026 with consolidated revenues reaching ₹19,712 million (approx. $222 million). This marks a robust year-on-year (YoY) growth of 35.7% in INR and 29.1% in constant currency (CC). Organic growth was also strong at 19.9% YoY in INR terms.
The Payer segment, which constitutes 90.4% of total revenue, grew by an impressive 37.3% YoY. The Provider segment saw a healthier 21.6% YoY increase.
Adjusted EBITDA stood at ₹5,125 million (approx. $57.7 million), reflecting a 24.2% YoY increase. The adjusted EBITDA margin for the quarter was a strong 26%, meeting expectations and aligning with the company's strategic focus.
Adjusted Profit After Tax (PAT) grew by 23% YoY to ₹3,229 million.
For the nine months of FY2026, cumulative revenues reached ₹51,686 million, up 29.2% YoY in INR terms. During this period, adjusted EBITDA and PAT rose by 25.3% and 44.3% respectively.
The Quality:
The reported adjusted EBITDA margin of 26% demonstrates operational efficiency and pricing power, especially in a high-growth environment. While specific Free Cash Flow (FCF) figures versus net profit are not detailed, the clear target for full debt repayment by FY2027 indicates a strong focus on cash generation and deleveraging.
The Grill:
Management has raised its constant currency revenue growth guidance for FY2026 to 22.5%+ (previously 21%+). This upward revision is largely attributed to a better-than-expected Open Enrollment (OE) season, which is now projected to contribute 5.5% of FY2026 revenues, partly bolstered by the integration of BroadPath. The adjusted EBITDA margin guidance remains at 25%.
Key strategic initiatives driving future growth include the launch of Sagility Synchrony, an integrated operating solution for Medicare Advantage, and the deployment of 32 distinct AI-driven use cases. These efforts are aimed at expanding into white spaces within existing accounts and building large transformation-led, outcome-based managed services.
One notable item is a one-time impact of ₹328 million due to India's new labor code. The company's Days Sales Outstanding (DSO) stood at 86 days at the quarter-end, a slight increase attributed to strong Q3 growth over Q2, and is expected to normalize in Q4.
🚩 Risks & Outlook
Specific Risks:
- Execution risk in integrating BroadPath and delivering on the expanded service offerings.
- Potential impact of regulatory changes or market shifts in the healthcare BPO sector.
- Normalization of Days Sales Outstanding (DSO) and managing working capital efficiently amidst rapid growth.
- The one-time cost related to the new labor code, though manageable.
The Forward View:
Investors will closely monitor the final OE season contribution, the adoption and impact of AI use cases, and the company's progress towards its debt repayment target of FY2027. The ability to successfully expand into middle and small market segments will also be key. The market will also be watching DSO trends in Q4 for signs of effective working capital management.